Charalambos Paskalis INTERNIST Director, ICU

• In progress

• Member Greek Society of Critical Care Medicine
• Member Society of Critical Care Medicine
• Member European Society of Intensive Care Medicine

• ICU Director “Aghios Loukas Hospital”, Thessaloniki 1991-1994
• ICU Director, Hygeia Hospital 1994-to date

Teaching Experience:

• Regular teaching of postgraduate doctors, 2 sessions per year, 3 months each, for more than 10 years
• Regular teaching of nursing personnel, in training courses, at least 4 times per year

Clinical Interest:

• Critical Care Cardiology
• ICU infections

Research Interest:

• Pharmacokinetics of advanced antibiotics in critically ill patients

• BK Felber, H Paskalis, C Kleinman-Ewing, F Wong-Staal and GN Pavlakis. The pX pro-tein of HTLV-I is a transcriptional activator of its long terminal repeats. Science, 1985; 229(4714): 675-679.
• H Paskalis, B K Felber and G N Pavlakis. Cis-acting sequences responsible for the transcriptional activation of HTLV-I constitute a conditional enhancer. PNAS, 1986; 83(17): 6558-6562.
• CM Wright, BK Felber, H Paskalis and GN Pavlakis. Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science, 1986; 234(4779): 988-92.
• Galani L, Souli M, Karaiskos I, Katsouda E, Patrozou H, Baziaka F, Paskalis C, Giamarellou H. Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum b-lactamases VEB-1 and SHV-5, metallo-b-lactamase VIM-1, and RNA methylase RmtB. J Global Antimicrob Res 2013; 1:115-116
• Chapter “Envenomation by insects and animals” in: Intensive Care, Ch. Roussos, editor: Paschalidis Athens, Dec. 2009